Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
Identifieur interne : 000269 ( PubMed/Corpus ); précédent : 000268; suivant : 000270Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
Auteurs : Anjali Modi ; Sukesha Gamit ; Bharat S. Jesalpura ; George Kurien ; Jayendra K. KosambiyaSource :
- PLoS neglected tropical diseases [ 1935-2735 ] ; 2017.
English descriptors
- KwdEn :
- Albendazole (administration & dosage), Animals, Diethylcarbamazine (administration & dosage), Disease Eradication, Drug Therapy, Combination, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Endemic Diseases, Filaricides (administration & dosage), Health Services Research, Humans, India (epidemiology), Microfilariae, Program Evaluation, Sentinel Surveillance, Surveys and Questionnaires, Wuchereria bancrofti (drug effects).
- MESH :
- chemical , administration & dosage : Albendazole, Diethylcarbamazine, Filaricides.
- drug effects : Wuchereria bancrofti.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial, India.
- prevention & control : Elephantiasis, Filarial.
- Animals, Disease Eradication, Drug Therapy, Combination, Endemic Diseases, Health Services Research, Humans, Microfilariae, Program Evaluation, Sentinel Surveillance, Surveys and Questionnaires.
Abstract
Following the World Health Assembly resolution on Elimination of lymphatic filariasis (ELF) as a public health problem by the year 2020, a Global Program (GPELF) was launched in 1997 to help endemic countries to initiate national programs. The current strategy to interrupt transmission of LF, is administration of once-yearly, single-dose, two-drug regimen (Albendazole with Diethylcarbamazine (DEC) to be used in endemic areas with the goal of reaching 65% epidemiological coverage for 4-6 years. We report findings of independent assessment from year 2010 to 2015 for last six rounds, after initial five rounds of Mass Drug Administration (MDA) since 2005 for ELF in endemic area of Gujarat.
DOI: 10.1371/journal.pntd.0005476
PubMed: 28369129
Links to Exploration step
pubmed:28369129Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.</title><author><name sortKey="Modi, Anjali" sort="Modi, Anjali" uniqKey="Modi A" first="Anjali" last="Modi">Anjali Modi</name><affiliation><nlm:affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</nlm:affiliation></affiliation></author><author><name sortKey="Gamit, Sukesha" sort="Gamit, Sukesha" uniqKey="Gamit S" first="Sukesha" last="Gamit">Sukesha Gamit</name><affiliation><nlm:affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</nlm:affiliation></affiliation></author><author><name sortKey="Jesalpura, Bharat S" sort="Jesalpura, Bharat S" uniqKey="Jesalpura B" first="Bharat S" last="Jesalpura">Bharat S. Jesalpura</name><affiliation><nlm:affiliation>National Vector Borne Disease Control Department (NVBDCP), Health and Family Welfare Department, Government of Gujarat, Gandhinagar, Gujarat, India.</nlm:affiliation></affiliation></author><author><name sortKey="Kurien, George" sort="Kurien, George" uniqKey="Kurien G" first="George" last="Kurien">George Kurien</name><affiliation><nlm:affiliation>National Vector Borne Disease Control Department (NVBDCP), Health and Family Welfare Department, Government of Gujarat, Gandhinagar, Gujarat, India.</nlm:affiliation></affiliation></author><author><name sortKey="Kosambiya, Jayendra K" sort="Kosambiya, Jayendra K" uniqKey="Kosambiya J" first="Jayendra K" last="Kosambiya">Jayendra K. Kosambiya</name><affiliation><nlm:affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28369129</idno><idno type="pmid">28369129</idno><idno type="doi">10.1371/journal.pntd.0005476</idno><idno type="wicri:Area/PubMed/Corpus">000269</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000269</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.</title><author><name sortKey="Modi, Anjali" sort="Modi, Anjali" uniqKey="Modi A" first="Anjali" last="Modi">Anjali Modi</name><affiliation><nlm:affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</nlm:affiliation></affiliation></author><author><name sortKey="Gamit, Sukesha" sort="Gamit, Sukesha" uniqKey="Gamit S" first="Sukesha" last="Gamit">Sukesha Gamit</name><affiliation><nlm:affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</nlm:affiliation></affiliation></author><author><name sortKey="Jesalpura, Bharat S" sort="Jesalpura, Bharat S" uniqKey="Jesalpura B" first="Bharat S" last="Jesalpura">Bharat S. Jesalpura</name><affiliation><nlm:affiliation>National Vector Borne Disease Control Department (NVBDCP), Health and Family Welfare Department, Government of Gujarat, Gandhinagar, Gujarat, India.</nlm:affiliation></affiliation></author><author><name sortKey="Kurien, George" sort="Kurien, George" uniqKey="Kurien G" first="George" last="Kurien">George Kurien</name><affiliation><nlm:affiliation>National Vector Borne Disease Control Department (NVBDCP), Health and Family Welfare Department, Government of Gujarat, Gandhinagar, Gujarat, India.</nlm:affiliation></affiliation></author><author><name sortKey="Kosambiya, Jayendra K" sort="Kosambiya, Jayendra K" uniqKey="Kosambiya J" first="Jayendra K" last="Kosambiya">Jayendra K. Kosambiya</name><affiliation><nlm:affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</nlm:affiliation></affiliation></author></analytic><series><title level="j">PLoS neglected tropical diseases</title><idno type="eISSN">1935-2735</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (administration & dosage)</term><term>Animals</term><term>Diethylcarbamazine (administration & dosage)</term><term>Disease Eradication</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Endemic Diseases</term><term>Filaricides (administration & dosage)</term><term>Health Services Research</term><term>Humans</term><term>India (epidemiology)</term><term>Microfilariae</term><term>Program Evaluation</term><term>Sentinel Surveillance</term><term>Surveys and Questionnaires</term><term>Wuchereria bancrofti (drug effects)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>India</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Disease Eradication</term><term>Drug Therapy, Combination</term><term>Endemic Diseases</term><term>Health Services Research</term><term>Humans</term><term>Microfilariae</term><term>Program Evaluation</term><term>Sentinel Surveillance</term><term>Surveys and Questionnaires</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Following the World Health Assembly resolution on Elimination of lymphatic filariasis (ELF) as a public health problem by the year 2020, a Global Program (GPELF) was launched in 1997 to help endemic countries to initiate national programs. The current strategy to interrupt transmission of LF, is administration of once-yearly, single-dose, two-drug regimen (Albendazole with Diethylcarbamazine (DEC) to be used in endemic areas with the goal of reaching 65% epidemiological coverage for 4-6 years. We report findings of independent assessment from year 2010 to 2015 for last six rounds, after initial five rounds of Mass Drug Administration (MDA) since 2005 for ELF in endemic area of Gujarat.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28369129</PMID><DateCreated><Year>2017</Year><Month>04</Month><Day>03</Day></DateCreated><DateCompleted><Year>2017</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.</ArticleTitle><Pagination><MedlinePgn>e0005476</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0005476</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Following the World Health Assembly resolution on Elimination of lymphatic filariasis (ELF) as a public health problem by the year 2020, a Global Program (GPELF) was launched in 1997 to help endemic countries to initiate national programs. The current strategy to interrupt transmission of LF, is administration of once-yearly, single-dose, two-drug regimen (Albendazole with Diethylcarbamazine (DEC) to be used in endemic areas with the goal of reaching 65% epidemiological coverage for 4-6 years. We report findings of independent assessment from year 2010 to 2015 for last six rounds, after initial five rounds of Mass Drug Administration (MDA) since 2005 for ELF in endemic area of Gujarat.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Independent assessment of MDA was performed to find coverage and compliance indicators, reasons for non-coverage and non-compliance in five Implementation Units (IUs). Pre, during and post MDA evaluations were done in three phases. The impact of MDA was measured by microfilaraemia survey. A total of eight sites, four random and four fixed sentinel sites were selected to calculate microfilaria rate (MF) per IUs per year. In years 2010 to 2015, we report results from 125,936 nocturnal blood smears and 17551 population in 120 selected clusters. Four clusters were selected per year in each of the five IUs for assessment of MDA round.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">Post MDA survey showed drug coverage between 81%-88% and epidemiological coverage 77%-89% across years. Main reasons for non-coverage were drug administrator related (the team did not visit or missed people) while non-compliance was population related (fear of side effects, sickness, people forgot or absent). During MDA findings show that the directly observed consumption is considerably improved from 58% in 2010 to 82% in 2015. The knowledge about benefits of drug provided also increased from 59% to 90% over the years. The current MF rate is less than one in all IUs with an overall 68% percent decrease from baseline year 2005 to year 2015. The average MF rate of Gujarat is 0.44 for year 2015.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The findings show that achieving adequate epidemiological and drug coverage is possible by actual field level operation of the program in large endemic areas. The results and feedback from independent assessment, performed regularly, could guide the policymakers and program managers for mid-term corrections and to frame strategies to enhance program. Monitoring of coverage and impact indicator together informs decisions for reaching end-point of MDA. The impact indicator- microfilaria rate in all IUs of South Gujarat Region has reached and remained less than one percent signaling end-points of MDA. Post MDA stringent monitoring in form of TAS is recommended to keep vigil on maintenance of elimination achieved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Modi</LastName><ForeName>Anjali</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2058-0722</Identifier><AffiliationInfo><Affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamit</LastName><ForeName>Sukesha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jesalpura</LastName><ForeName>Bharat S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>National Vector Borne Disease Control Department (NVBDCP), Health and Family Welfare Department, Government of Gujarat, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurien</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Vector Borne Disease Control Department (NVBDCP), Health and Family Welfare Department, Government of Gujarat, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosambiya</LastName><ForeName>Jayendra K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Government Medical College, Surat, Gujarat, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2011 Oct;5(10):e1346</RefSource><PMID Version="1">22022627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vector Borne Dis. 2015 Dec;52(4):314-20</RefSource><PMID Version="1">26714512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2015 Sep 18;90(38):489-504</RefSource><PMID Version="1">26387149</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2013 May;107(5):293-300</RefSource><PMID Version="1">23442572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2002 Apr;82(1):31-8</RefSource><PMID Version="1">11904101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Community Med. 2008 Jan;33(1):38-42</RefSource><PMID Version="1">19966995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2012 Nov 30;87(48):478-82</RefSource><PMID Version="1">23213667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2004 Jun;9(6):702-9</RefSource><PMID Version="1">15189460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Parasitol. 2012 Jul;2(2):109-15</RefSource><PMID Version="1">23767017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2014 Nov 12;7:507</RefSource><PMID Version="1">25387483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2014 Sep;108(9):538-49</RefSource><PMID Version="1">24728444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2015 Mar;109(3):173-4</RefSource><PMID Version="1">25575555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2007 Aug 24;6:7</RefSource><PMID Version="1">17718908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vector Borne Dis. 2011 Mar;48(1):1-6</RefSource><PMID Version="1">21406730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Commun Dis. 2012 Dec;44(4):251-9</RefSource><PMID Version="1">25145075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vector Borne Dis. 2010 Jun;47(2):113-5</RefSource><PMID Version="1">20539050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2016 Jan 27;9:29</RefSource><PMID Version="1">26813098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Serv Res. 2016 Nov 24;:null</RefSource><PMID Version="1">27882543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2447</RefSource><PMID Version="1">24278486</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006302" MajorTopicYN="N">Health Services Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008842" MajorTopicYN="N">Microfilariae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018571" MajorTopicYN="N">Sentinel Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28369129</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0005476</ArticleId><ArticleId IdType="pii">PNTD-D-16-01246</ArticleId><ArticleId IdType="pmc">PMC5391126</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000269 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000269 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28369129
|texte= Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28369129" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |